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Background: Most modern spinal implants contain titanium and remain in the patient’s body permanently. Local
and systemic effects such as tissue necrosis, osteolysis and malignant cell transformation caused by implants have
been described. Increasing tissue concentration and whole blood levels of ions are necessary before a disease
caused by a contaminant develops. The aim of the present study was the measurement of whole blood titanium
levels and the evaluation of a possible correlation between these changes and the number of fused segments.
Methods: A prospective study was designed to determine changes in whole blood titanium levels after spinal
fusion and to analyze the correlation to the number of pedicle screws, cross connectors and interbody devices
implanted.
Blood samples were taken preoperatively in group I (n = 15), on the first, second and 10th day postoperatively, as
well as 3 and 12 months after surgery.
Group II (n = 16) served as a control group of volunteers who did not have any metal implants in the body. Blood
samples were taken once in this group.
The number of screw-rod-connections and the length of the spinal fusion were determined using radiographic
pictures. This study was checked and approved by the ethical committee of the University of Tuebingen.
Results: The mean age in group I was 47 ± 22 years (range 16 - 85 years). There were three male (20%) and twelve
female (80%) patients. The median number of fused segments was 5 (range 1 to 11 segments).
No statistically significant increase in the titanium level was seen 12 months after surgery (mean difference:
-7.2 μg/l, 95% CI: -26.9 to 12.5 μg/l, p = 0.446). By observing the individual titanium levels, 4 out of 15 patients
demonstrated an increase in titanium levels 12 months after surgery.
No statistically significant correlation between fused segments (r = -0.188, p = 0.503) length of instrumentation
(r = -0.329, p = 0.231), number of interbody devices (r = -0.202, p = 0.291) and increase of titanium levels over the
observation period was seen.
Conclusions: Instrumented spinal fusion does not lead to a statistically significant increase in whole blood titanium
levels. There seems to be no correlation between the number of pedicle screws, cross connectors and interbody
devices implanted and the increase of serum titanium levels.
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Spinal surgery -especially instrumented spinal fusion-
has increasing importance in treatment of patients with
chronic low back pain caused by osteoligamentary in-
stability, degenerative disc diseases or spondylolisthesis.
Most of the modern spinal implants contain titanium
and remain in the patient’s body permanently. Little is
known about the influence of free metal ions on a
patient’s health. Negative effects such as tissue necrosis,
osteolysis and malignant cell transformation have been
described [1].
Rising tissue concentration and serum levels of ions
are necessary before a disease caused by a contaminant
develops [2,3]. It has been shown that metal ions such as
vanadium and cobalt chromium decrease monocyte and
macrophage survival in a dose-dependent manner [4].
It has also been shown that titanium-alloy particles
stimulate cytokine release. Additionally opsonization of
machined particles with human serum increased the re-
lease of macrophages and cytokines [5].
Activation of the monocyte-macrophage-system leads
to a local inflammatory reaction and is a relevant pro-
moter for prosthetic loosening [6].
Although titanium is characterized by excellent qual-
ities, there are many indications that it is not inert.
Nephrotoxicity, cardiac and hepatic injury have been
described after oral administration to rats [7]. Patients
undergoing revision for non-fusion after posterior lum-
bar spondylodesis, were observed to have a highTable 1 Demographic data group I






1 f 73 DLS 10 1626 3
2 f 55 LS 1 381 1
3 f 16 Scoliosis 6 864 0
4 f 16 Scoliosis 6 869 0
5 f 22 Scoliosis 5 811 0
6 m 45 Scoliosis 5 1076 2
7 f 68 LS 1 370 1
8 f 85 LSCS 4 824 1
9 f 61 LS 1 410 1
10 f 61 LSCS 2 550 1
11 m 30 LS 1 405 1
12 f 42 Scoliosis 6 965 0
13 f 20 Scoliosis 11 1520 0
14 f 55 DLS 6 1415 0
15 m 58 DLS 4 540 0
DLS: Degenerativ lumbar scoliosis, LS: lumbar spondylolisthesis, LSCS: lumbar spinal
MPDS: Muenster-posterior-doublerod-system.paraspinal tissue concentration of titanium [8], and ris-
ing serum titanium levels after spinal fusion with a cor-
relation to the amount of fused segments has been
demonstrated [9]. Free titanium particles lead to an in-
crease in prostaglandin and interleukin synthesis as an
indicator of an inflammatory process with a negative in-
fluence on bone formation [10,11].
Corrosion of titanium ions in the surrounding tissue
and the movement of these ions into the distant organs
may cause systemic problems. By using rat peritoneal
macrophages and by determining metal concentration in
sheep after spinal fusion, an accumulation in the differ-
ent organs especially in the brain, lungs, liver, spleen,
kidneys and lymph nodes was detected. Inflammation
and osteolysis was seen in the macrophages [12-16]. On
the other hand, titanium is present as a micronutrient
in the body even without any metal implants. A normal
value for titanium in blood seems to be between 50-
150 ug/l (Synlab/Leinfelden, Germany).
The aim of the present study was to detect a possible
increase in titanium levels after spinal fusion. We also
wanted to investigate a possible correlation between the
number of implanted pedicle screws, cross connectors
and interbody devices on titanium levels.
Methods
A prospective study was performed to detect the
effects of spinal fusion on titanium levels. For instru-
mentation, the Muenster-Anterior/Posterior-Doublerod-ber of
y devices
Type of









MPDS 56 34 26 29 37
MPDS 33 44 ø 63 36
MADS 34 ø 48 ø 31
MADS 39 43 39 ø 96
MADS 48 ø 42 54 94
MADS 54 42 44 55 31
Expedium 53 ø 39 54 33
Expedium 61 49 49 63 96
Expedium 53 ø 49 40 47
Expedium 49 ø 31 45 35
Expedium 47 52 ø 40 142
MADS 38 ø ø 37 42
Expedium 51 42 3 38 37
Expedium 69 33 37 32 36
Expedium 34 34 45 82 34
canal stenosis, MAPS: Muenster-Anterior-doublerod-system,
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the ExpediumW (Depuy-spine Raynham, Massachusetts,
USA) systems were used.
Group I patients (n = 15) underwent instrumented
spinal fusion in a period between January 2006 and
March 2009. Blood samples were taken preoperatively,
on the first, second and 10th day postoperatively, as well
as 3 and 12 months after surgery (Table 1).
To evaluate a possible influence of lifetime exposure
on titanium levels, a control group (group II) was cre-
ated. Group II (n = 16) consisted of volunteers who did
not have any metal implants in the body and were sta-
tistically significantly younger than group I. Blood sam-
ples were taken once in this group (Table 2).
Only patients with a normal liver and kidney function
and no previous history of metal implants were included
in the present study.
The number of screw-rod-connections and the length
of the spinal fusion were determined using radiographic
pictures (Figure 1, 2).Study registration and informed consent
This study was checked and approved by the local eth-
ical committee of the University of Tuebingen. Written
informed consent was obtained from all patients to take
part in this study.Blood samples and titanium analysis
Blood samples were taken by using titanium-free canulas
and EDTA-tubes.Table 2 Demographic data group II
Patient sex age Titanium levels (ug/l)
1 f 26 59
2 m 55 47
3 m 33 30
4 f 24 37
5 f 55 33
6 m 24 35
7 m 31 57
8 f 50 59
9 f 28 58
10 f 29 55
11 f 50 56
12 m 29 61
13 f 24 33
14 f 24 53
15 f 20 58
16 m 30 59Collected blood was stored at 5°C until measurement.
Titanium was measured by ICP-MS (inductively
coupled plasma mass spectrometry) (Synlab/Leinfelden,
Germany). Therefore titanium was ionized through
plasma at a temperature of 5000°C. Depending on their
mass, ions were separated and counted using a spec-
trometer. Detection limit of titanium ions was >0.02
parts per trillion.
Normal values for whole blood titanium levels were in
a range between 50-150 ug/l in blood-samples.Statistical analysis
Categorical variables are presented as frequencies and
percentages, and continuous variables as means and
standard deviations, or medians and ranges. A paired
t-test was used to evaluate the difference in titanium
levels preoperatively and 12 months after surgery. To
compare the two groups, independent sample t tests
or exact Mann Whitney U test were used. Differences
are presented with 95% confidence intervals (CI). A re-
lationship of titanium levels with fused segments,
length of instrumentation and number of interbody
devices was evaluated using the Spearman correlation
coefficient.
All reported P values are two-sided, with a significance
level of 0.05 and have not been adjusted for multiple
testing. All analyses were performed with the use of R
2.13.2 (R Foundation for Statistical Computing, Vienna,
Austria) and IBM SPSS 20.Results
The mean age in group I was 47 ± 22 years (range 16 -
85 years). There were three male (20%) and twelve female
(80%) patients. The median number of fused segments
was 5 (range 1 to 11 segments). Demographic data of this
group are shown in Table 1.
The whole blood titanium levels in group I before
and in the postoperative period are shown in
Table 3.
No statistically significant increase in titanium levels
was seen 12 months after surgery (mean difference:
-7.2 μg/l, 95% CI: -26.9 to 12.5 μg/l, p = 0.446) (Figure 3).
4 out of 15 patients demonstrated an increase in ti-
tanium levels 12 months after surgery (ID 4,5,8,11)
(Figure 4). 8 out of 15 patients presented with sub-
normal levels of titanium.
Titanium levels were evaluated in all patients before
surgery and 12 months after surgery. Titanium levels
were evaluated in 9 patients (out of 15) two days after
surgery, 10 days after surgery in 12 patients (out of 15)
and 3 months after surgery in 13 patients (out of 15). 11
patients presented sub-normal titanium levels12 months
after surgery.
Figure 1 Technique of length-measurement of the spinal fusion on lateral radiographs of the spine. The length of each screw and rod
were added to obtain the total length of spinal fusion.
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rection 6 months after primary surgery, and re-
instrumentation was necessary. The development of
titanium levels of this patient is also shown in Table 1
(ID 1).
The mean age in group II was 33 ± 12 years (range 20
– 55 years). There were 6 male and 10 female patients
in this group. The mean titanium level in this group was
49.4 ± 11.5 μg/l (range 30 –61 μg/l). There was a statisti-
cally significant difference regarding age between the
two groups (mean difference: 14 years, 95% CI: 0.5 to
27.2 years, p = 0.042).
When comparing preoperative titanium levels in group
I with group II, there was no statistically significant dif-
ference (p = 0.464).
No statistically significant correlation between the
number of fused segments (r = -0.188, p = 0.503), length
of instrumentation (r = -0.329, p = 0.231), number of
interbody devices (r = -0.202, p = 0.291) and develop-
ment of titanium levels over the observation period
was seen.Discussion
Titanium as a light and strong material is often used as
an alloy in orthopedic implants, and is generally
regarded as safe for the organism.
Titanium is present as a micronutrient in the body
even without metal implants, and most is stored intra-
cellularly. We therefore analyzed not only serum titan-
ium levels as done in previous studies [9,17], but the
total amount of titanium in the blood.
Titanium alloy used in pedicle screws and interbody
devices contained approximately 90% titanium, 6%
aluminum and 4% vanadium [18-20]. Therefore an
evaluation of titanium levels in patients after instrumen-
ted spinal fusion might be interesting with regard to
possible effects caused by metal particles and for early
detection of none-fusions.
In the present study, no statistically significant raise
in titanium levels during the observation period after
spinal fusion was seen. In contrast to our findings,
previous studies demonstrated an increase in titanium
levels [9,17]. One possible explanation for the different
Figure 2 Technique for counting the different connections on
a.p. radiographs of the spine.
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evaluation of titanium levels. As mentioned above, we
used whole blood samples in the present study as
most titanium is present in macrophages. Travis et al.
[9] and Kasai et al. [17] analyzed free titanium ions in
serum.
Interestingly, when observing the individual devel-
opment of whole blood titanium levels, 4 out of 15
patients demonstrated an increase in titanium levels
12 months after surgery. It is unclear why there was
such a spread in titanium levels 12 months after sur-
gery. The distribution of metal ions after spinal fu-
sion seems to be a multifactorial process which has
not been evaluated. As we analyzed whole blood




before surgery 47.9 15
2 th day after surgery 41.4 9
10th day after surgery 41.5 12
3 months after surgery 48.6 13
12 months after surgery 55.1 15(free and intracellular titanium ions). These findings
support previous findings by Richardson et at [9]
who also stated that the individual’s biological re-
sponse and elimination of titanium ions might be ex-
tremely variable. Another possible explanation might
be that these four individuals have undergone un-
known environmental exposure. Another possible rea-
son for the increase in titanium levels in these
individuals might be a reduced renal clearance, but
all patients demonstrated normal renal function dur-
ing the observation period. Individual titanium elim-
ination might also explain why 8 out of 15 patients
presented with sub-normal levels of titanium before
surgery, and 10 out of 15 patients 12 months after
surgery.
Initial titanium levels seem to have no effect on post-
operative titanium levels. The fact that the probands in
group II were younger than the patients in group I does
not support the theory of continuously rising of levels
during a lifetime caused by a longer environmental ex-
posure time.
There was no correlation between the number of ped-
icle screws, cross connectors and interbody devices
which support the findings by Travis et al. [9] who also
found no correlation. One possible explanation for this
finding might be that there is a balance between absorp-
tion from the alloy and renal elimination.
One of the main strengths of the present study is the
use of whole blood samples. To our knowledge, this is
the first study evaluating titanium levels after spinal fu-
sion in whole blood. As demonstrated by Mohammed
Bakir [16], there is strong contact between monocytes
and the titanium surface with a possible absorption of ti-
tanium particles. This might explain the different stand-
ard values for titanium in serum (<7 ug/l) and whole
blood 50-150 ug/l). By using whole blood samples, total
amount of titanium and not only free ions could be
detected.
We also note several limitations of the present study.
First, the whole titanium levels at the second and 10th
postoperative day are incomplete, caused by a sample
error. The results for this point of time might therefore












Figure 3 Development of titanium levels after spinal fusion in group I.
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plant systems used when analyzing serum titanium
levels. This might also be of interest and should be eval-
uated in further studies. Because of the small sample
numbers, there may be low power with a possible type II
error.Figure 4 Individual development of titanium levels in the different paConclusion
Finally, there seems to be no increase in serum titan-
ium levels after spinal fusion. Whether the trend is
stable, or if whole titanium levels increase in patients
with non-fusion or after a period of 12 months needs
to be investigated in further observations.tients.
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